Skip to main content
Fig. 4 | Cell & Bioscience

Fig. 4

From: ARPC1A correlates with poor prognosis in prostate cancer and is up-regulated by glutamine metabolism to promote tumor cell migration, invasion and cytoskeletal changes

Fig. 4

ARPC1A is associated with the poor prognosis of PCa patients. A Differences in ARPC1A protein expression among PCa tissue specimens. B Univariate Cox regression analysis for BCR after RP for patients with PCa. C Multivariate Cox regression analysis for BCR after RP for patients with PCa. D The cumulative incidence of BCR after RP in PCa patients with different ARPC1A expression levels from the TMA cohort. E ROC curve of ARPC1A expression levels demonstrates the potential of ARPC1A as a biomarker for predicting BCR after RP. F The cumulative incidence of death in PCa patients with different ARPC1A expression levels from the TCGA cohort. G ROC curve of ARPC1A expression levels demonstrates the potential of ARPC1A as a biomarker for predicting OS

Back to article page